Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment Scenarios
Value Health
.
2014 Nov;17(7):A557-8.
doi: 10.1016/j.jval.2014.08.1836.
Epub 2014 Oct 26.
Authors
M Hoogendoorn
1
,
T Feenstra
2
,
Y Asukai
3
,
S Borg
4
,
R N Hansen
5
,
S A Jansson
6
,
Y Samyshkin
3
,
M Wacker
7
,
A Briggs
8
,
A Lloyd
3
,
S D Sullivan
9
,
M P Rutten-van Mölken
1
Affiliations
1
Erasmus University Rotterdam, Rotterdam, The Netherlands.
2
RIVM /UMCG, Bilthoven, The Netherlands.
3
IMS Health, Economics and Outcomes Research, London, UK.
4
The Swedish Institute for Health Economics, Lund, Sweden.
5
School of Pharmacy, University of Washington, Seattle, WA, USA.
6
The OLIN Studies, Luleå, Sweden.
7
Helmholtz Zentrum Munchen, Neuherberg, Germany.
8
University of Glasgow, Glasgow, UK.
9
University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA.
PMID:
27201829
DOI:
10.1016/j.jval.2014.08.1836
No abstract available